This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

Along with his colleagues, he used the virus sequence to try and understand where SARS-CoV-2 came from. They first looked at the virus's backbone. That's the whole genomic structure, unique to ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

CoV-2, a new merbecovirus found in bats across China, that utilises the ACE2 receptor for cellular entry—raising concerns ...

More information: Shun Nakamura et al, Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes, Proceedings of the National Academy of Sciences (2025).

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...